BIOLBIOLASE, INC

Nasdaq biolase.com


$ 0.14 $ 0.00 (1.09 %)    

Thursday, 18-Apr-2024 14:08:53 EDT
QQQ $ 422.80 $ -2.43 (-0.57 %)
DIA $ 377.76 $ 0.39 (0.1 %)
SPY $ 499.54 $ -1.03 (-0.21 %)
TLT $ 88.82 $ -0.45 (-0.5 %)
GLD $ 220.32 $ 0.75 (0.34 %)
$ 0.1485
$ 0.14
$ 0.14 x 300
$ 0.00 x 0
$ 0.14 - $ 0.14
$ 0.13 - $ 47.10
608,413
na
189,783
$ 2.21
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-21-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-28-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-17-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
11 08-13-2021 06-30-2021 10-Q
12 05-13-2021 03-31-2021 10-Q
13 03-31-2021 12-31-2020 10-K
14 11-13-2020 09-30-2020 10-Q
15 08-14-2020 06-30-2020 10-Q
16 05-08-2020 03-31-2020 10-Q
17 03-30-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
19 08-09-2019 06-30-2019 10-Q
20 05-10-2019 03-31-2019 10-Q
21 03-08-2019 12-31-2018 10-K
22 11-14-2018 09-30-2018 10-Q
23 08-13-2018 06-30-2018 10-Q
24 05-04-2018 03-31-2018 10-Q
25 03-14-2018 12-31-2017 10-K
26 11-01-2017 09-30-2017 10-Q
27 08-07-2017 06-30-2017 10-Q
28 05-04-2017 03-31-2017 10-Q
29 03-10-2017 12-31-2016 10-K
30 11-08-2016 09-30-2016 10-Q
31 08-01-2016 06-30-2016 10-Q
32 05-09-2016 03-31-2016 10-Q
33 03-11-2016 12-31-2015 10-K
34 11-06-2015 09-30-2015 10-Q
35 08-07-2015 06-30-2015 10-Q
36 05-01-2015 03-31-2015 10-Q
37 03-06-2015 12-31-2014 10-K
38 11-07-2014 09-30-2014 10-Q
39 08-08-2014 06-30-2014 10-Q
40 05-12-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ascendiant-capital-maintains-buy-on-biolase-lowers-price-target-to-4

Ascendiant Capital analyst Edward Woo maintains Biolase (NASDAQ:BIOL) with a Buy and lowers the price target from $15 to $4.

 why-cutera-shares-are-trading-lower-by-over-26-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected four...

 benchmark-maintains-speculative-buy-on-biolase-lowers-price-target-to-04

Benchmark analyst Bruce Jackson maintains Biolase (NASDAQ:BIOL) with a Speculative Buy and lowers the price target from $2.5...

 dow-dips-200-points-nike-shares-fall-after-q3-results

U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 200 points. The Dow traded down 0....

 why-biolase-shares-are-surging-friday

BIOLASE, Inc. shares rise 31% after better-than-expected FY23 EPS results, strong revenue growth expected in 2024 due to increa...

 us-stocks-edge-lower-fedex-posts-upbeat-earnings

U.S. stocks traded slightly lower this morning. Following the market opening Friday, the Dow traded down 0.06% to 39,758.88 whi...

 why-fedex-shares-are-trading-higher-by-around-12-here-are-20-stocks-moving-premarket

Shares of FedEx Corporation (NYSE: FDX) rose sharply in today’s pre-market trading after the company reported better-than-expe...

 recap-biolase-q4-earnings
Recap: Biolase Q4 Earnings
03/21/2024 20:20:17

 biolase-q4-eps-176-beats-255-estimate-sales-1349m-miss-1355m-estimate

Biolase (NASDAQ:BIOL) reported quarterly losses of $(1.76) per share which beat the analyst consensus estimate of $(2.55) by 30...

 earnings-scheduled-for-march-21-2024

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per s...

 earnings-preview-for-biolase
Earnings Preview For Biolase
03/20/2024 17:00:54

 nasdaq-down-over-2-marriott-earnings-top-views

U.S. stocks traded lower toward the end of trading, with the Dow Jones index dipping over 700 points on Tuesday. The Dow trade...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION